UK drugmaker GSK ended Tuesday’s trading more than 2% higher after announcing its first-quarter financial results.

U.S.-listed shares of GSK are gaining in intraday trading Wednesday after the British pharma giant posted ...

GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).

(Reuters) - British drugmaker GSK said on Wednesday it was "well positioned" to respond to any potential financial impact ...

What amazes me is that my better half never bought any GSK shares via the London Stock Exchange. Instead, her shares were either free, cheaper than half-price, or bought at steep discounts to ...

U.S. President Donald Trump this month reiterated plans for a "major" tariff on pharmaceutical imports, but he has not said ...

If you are looking for an AI stock that is more promising than GSK but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock. READ NEXT: 20 Best AI ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing ... the most attractive and discounted stocks. GSK has three segments: Specialty Medicines ...

GSK's Q1 2025 earnings will reveal progress in specialty medicines amid regulatory headwinds. Learn what to watch when the ...

French media giant Canal+ will list on the London Stock Exchange this morning in an early ... to be the capital’s biggest listing since GSK spun off Haleon in 2022. In November, JP Morgan ...

FTSE 100 top-tenner GSK PLC (LSE:GSK, NYSE:GSK) has also reported earnings ahead of expectations, and kept full year guidance ...